Cargando…

Clinically available/under trial drugs and vaccines for treatment of SARS-COV-2

Prior 2019 to work date entire world is seriously influenced by an appalling illness called COVID sickness [Coronavirus disease-2019 (COVID-19)] which is brought about by another strain of coronavirus known as severe acute respiratory syndrome-Coronavirus-2. This pandemic was first seen in the Hubei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Avinash, Parihar, Arpana, Basha, S. Nisar, Panda, Udwesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300481/ http://dx.doi.org/10.1016/B978-0-323-91172-6.00005-4

Ejemplares similares

Natural products as a therapy to combat against SARS-CoV-2 virus infection
por: Malviya, Shivani, et al.
Publicado: (2022)

System and network biology-based computational approaches for drug repositioning
por: Pandita, Vasundhara, et al.
Publicado: (2022)

A Summary of the SARS-CoV-2 Vaccines and Technologies Available or under Development
por: Abdulla, Zainalabideen A., et al.
Publicado: (2021)

Immunoinformatics and molecular modeling approach to design universal multi-epitope vaccine for SARS-CoV-2
por: Khan, Md. Tahsin, et al.
Publicado: (2021)

3D Printing: Advancement in Biogenerative Engineering to Combat Shortage of Organs and Bioapplicable Materials
por: Parihar, Arpana, et al.
Publicado: (2021)

In silico analysis of SARS-CoV-2 proteins as targets for clinically available drugs
por: Chan, Wallace K. B., et al.
Publicado: (2022)

Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS‐CoV‐2
por: Xue, Yiying, et al.
Publicado: (2023)

Phytochemicals against SARS-CoV as potential drug leads
por: Swain, Shasank Sekhar, et al.
Publicado: (2021)

While We Wait for a Vaccine Against SARS-CoV-2, Why Not Think About Available Drugs?
por: Barrantes, Francisco J.
Publicado: (2020)

Editorial: Advances in orally inhaled and nasal drug products (OINDPs)
por: Mehta, Piyush Pradeep, et al.
Publicado: (2023)

Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial
por: Usmani, Salman Sadullah, et al.
Publicado: (2020)

Vaccines and drugs under clinical trials for prevention and treatment of COVID-19
por: Yadav, Umesh C. S.
Publicado: (2021)

Phytochemicals-based targeting RdRp and main protease of SARS-CoV-2 using docking and steered molecular dynamic simulation: A promising therapeutic approach for Tackling COVID-19
por: Parihar, Arpana, et al.
Publicado: (2022)

Insight into the Advances in Clinical Trials of SARS-CoV-2 Vaccines
por: Basheeruddin Asdaq, Syed Mohammed, et al.
Publicado: (2022)

High throughput molecularly imprinted polymers based electrochemical nanosensors for point-of-care diagnostics of COVID-19
por: Singhal, Ayushi, et al.
Publicado: (2022)

Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines
por: Schulze-Koops, Hendrik, et al.
Publicado: (2021)

Naturally Available Flavonoid Aglycones as Potential Antiviral Drug Candidates against SARS-CoV-2
por: Al-Karmalawy, Ahmed A., et al.
Publicado: (2021)

Potential of Marine Terpenoids against SARS-CoV-2: An In Silico Drug Development Approach
por: Sahoo, Alaka, et al.
Publicado: (2021)

SARS-CoV-2 vaccination and phase 1 cancer clinical trials
por: Yap, Timothy A, et al.
Publicado: (2021)

Structure-based drug designing and immunoinformatics approach for SARS-CoV-2
por: Panda, Pritam Kumar, et al.
Publicado: (2020)

Immunoinformatics and reverse vaccinomic approaches for effective design
por: Parihar, Arpana, et al.
Publicado: (2022)

Ethical tradeoffs in SARS-CoV-2 vaccine development: Assuring fair availability for low-income countries
por: Gurwitz, David
Publicado: (2021)

Tenofovir, Another Inexpensive, Well-Known and Widely Available Old Drug Repurposed for SARS-COV-2 Infection
por: Zanella, Isabella, et al.
Publicado: (2021)

Computational approaches for drug repositioning and repurposing to combat SARS-CoV-2 infection
por: Panda, Subhamay, et al.
Publicado: (2022)

Pharmacotherapy of obesity: an update on the available medications and drugs under investigation
por: Chakhtoura, Marlene, et al.
Publicado: (2023)

Anti-SARS-CoV-2 antibodies among vaccinated healthcare workers: Repeated cross-sectional study
por: Mishra, Sanjeeb Kumar, et al.
Publicado: (2022)

Bacteriological analysis of street-vended fruit juices available in Rishikesh, Uttarakhand
por: Malik, Yatharth, et al.
Publicado: (2020)

Characteristics of US Blood Donors Testing Reactive for Antibodies to SARS-CoV-2 Prior to the Availability of Authorized Vaccines
por: Dodd, Roger Y, et al.
Publicado: (2021)

Laboratory diagnosis of SARS-CoV-2: available approaches and limitations
por: Abduljalil, J.M.
Publicado: (2020)

Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases
por: Chaudhry, M. Zeeshan, et al.
Publicado: (2022)

SARS-CoV-2 Vaccination Efficacy & Safety in Lung Transplantation Recipients: A Single Centre Study
por: Shah, U., et al.
Publicado: (2022)

Indole-Based Compounds as Potential Drug Candidates for SARS-CoV-2
por: Girgis, Adel S., et al.
Publicado: (2023)

Drug induced hepatitis and SARS-CoV-2 vaccination: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Prospective Cohort Study of the Kinetics of Specific Antibodies to SARS-CoV-2 Infection and to Four SARS-CoV-2 Vaccines Available in Serbia, and Vaccine Effectiveness: A 3-Month Interim Report
por: Lijeskić, Olivera, et al.
Publicado: (2021)

SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?
por: Chakraborty, Saborni, et al.
Publicado: (2021)

Ensemble Machine Learning Model to Predict SARS-CoV-2 T-Cell Epitopes as Potential Vaccine Targets
por: Bukhari, Syed Nisar Hussain, et al.
Publicado: (2021)

Efficacy of oscillating PEP therapy in COPD: Is the significance clinically relevant?
por: Parihar, Sandeep, et al.
Publicado: (2023)

COVID-19 (SARS-CoV-2 Infection) and Children: Pediatric Neurologist’s Perspective
por: Panda, Prateek Kumar, et al.
Publicado: (2020)

COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking
por: Magro, Giuseppe
Publicado: (2020)

Evaluation of drug repositioning by molecular docking of pharmaceutical resources available in the Brazilian healthcare system against SARS-CoV-2
por: Grahl, Matheus V.C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iuhftfmech7jn69545cvkibg1c